DAVID R. GUYER - 20 Jun 2023 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
20 Jun 2023
Net transactions value
$0
Form type
4
Filing time
22 Jun 2023, 09:22:02 UTC
Previous filing
13 Feb 2023
Next filing
09 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Option (Right to Buy) Award $0 +26,100 $0.000000 26,100 20 Jun 2023 Common Stock 26,100 $3.26 Direct
transaction EYPT Stock Option (Right to Buy) Award $0 +13,000 $0.000000 13,000 20 Jun 2023 Common Stock 13,000 $3.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.